Zobrazit minimální záznam



dc.contributor.authorRusz J.
dc.contributor.authorSaft C.
dc.contributor.authorSchlegel U.
dc.contributor.authorHoffman R.
dc.contributor.authorSkodda S.
dc.date.accessioned2019-03-27T22:30:13Z
dc.date.available2019-03-27T22:30:13Z
dc.date.issued2014
dc.identifierV3S-221825
dc.identifier.citationRUSZ, J., et al. Phonatory Dysfunction as a Preclinical Symptom of Huntington Disease. PLoS ONE. 2014, 9(11), 1-7. ISSN 1932-6203. DOI 10.1371/journal.pone.0113412. Available from: http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0113412&representation=PDF
dc.identifier.issn1932-6203 (online)
dc.identifier.urihttp://hdl.handle.net/10467/81558
dc.description.abstractPurpose: Although dysphonia has been shown to be a common sign of Huntington disease (HD), the extent of phonatory dysfunction in gene positive premanifest HD individuals remains unknown. The aim of the current study was to explore the possible occurrence of phonatory abnormalities in prodromal HD. Method: Sustained vowel phonations were acquired from 28 premanifest HD individuals and 28 healthy controls of comparable age. Data were analysed acoustically for measures of several phonatory dimensions including airflow insufficiency, aperiodicity, irregular vibration of vocal folds, signal perturbations, increased noise, vocal tremor and articulation deficiency. A predictive model was built to find the best combination of acoustic features and estimate sensitivity/specificity for differentiation between premanifest HD subjects and controls. The extent of voice deficits according to a specific phonatory dimension was determined using statistical decision making theory. The results were correlated to global motor function, cognitive score, disease burden score and estimated years to disease onset. Results: Measures of aperiodicity and increased noise were able to significantly differentiate between premanifest HD individuals and controls (p,0.01). The combination of these aspects of dysphonia led to a sensitivity of 91.5% and specificity of 79.2% to correctly distinguish speakers with premanifest HD from healthy individuals. Some form of disrupted phonatory function was revealed in 68% of our premanifest HD subjects, where 18% had one affected phonatory dimension and 50% showed impairment of two or more dimensions. A relationship between pitch control and cognitive score was also observed (r =20.50, p = 0.007). Conclusions: Phonatory abnormalities are detectable even the in premotor stages of HD. Speech investigation may have the potential to provide functional biomarkers of HD and could be included in future clinical trials and therapeutic interventions.eng
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.publisherPublic Library of Science
dc.relation.ispartofPLoS ONE
dc.relation.urihttp://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0113412&representation=PDF
dc.subjectHuntington diseaseeng
dc.subjectprodromaleng
dc.subjectspeech disordereng
dc.subjectdysphoniaeng
dc.subjectacoustic analysis.eng
dc.titlePhonatory Dysfunction as a Preclinical Symptom of Huntington Diseaseeng
dc.typečlánek v časopisecze
dc.typejournal articleeng
dc.identifier.doi10.1371/journal.pone.0113412
dc.relation.projectidinfo:eu-repo/grantAgreement/Czech Science Foundation/GA/GAP102%2F12%2F2230/CZ/Acoustic voice and speech analysis in patients with central nervous system disorders/
dc.rights.accessopenAccess
dc.identifier.wos000345533200115
dc.type.statusPeer-reviewed
dc.type.versionpublishedVersion
dc.identifier.scopus2-s2.0-84914703673


Soubory tohoto záznamu


Tento záznam se objevuje v následujících kolekcích

Zobrazit minimální záznam